SE9804298D0 - New medical use - Google Patents

New medical use

Info

Publication number
SE9804298D0
SE9804298D0 SE9804298A SE9804298A SE9804298D0 SE 9804298 D0 SE9804298 D0 SE 9804298D0 SE 9804298 A SE9804298 A SE 9804298A SE 9804298 A SE9804298 A SE 9804298A SE 9804298 D0 SE9804298 D0 SE 9804298D0
Authority
SE
Sweden
Prior art keywords
cell
medical use
new medical
dna
dna sequence
Prior art date
Application number
SE9804298A
Other languages
English (en)
Swedish (sv)
Inventor
Anna Karlsson
Original Assignee
Anna Karlsson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anna Karlsson filed Critical Anna Karlsson
Priority to SE9804298A priority Critical patent/SE9804298D0/xx
Publication of SE9804298D0 publication Critical patent/SE9804298D0/xx
Priority to US09/857,498 priority patent/US6582947B1/en
Priority to AT99963819T priority patent/ATE290071T1/de
Priority to ES99963819T priority patent/ES2239475T3/es
Priority to EP99963819A priority patent/EP1137764B1/en
Priority to JP2000588348A priority patent/JP2002532090A/ja
Priority to PCT/SE1999/002314 priority patent/WO2000036099A1/en
Priority to AU20185/00A priority patent/AU778376B2/en
Priority to DE69924003T priority patent/DE69924003T2/de
Priority to DK99963819T priority patent/DK1137764T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
SE9804298A 1998-12-11 1998-12-11 New medical use SE9804298D0 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE9804298A SE9804298D0 (sv) 1998-12-11 1998-12-11 New medical use
US09/857,498 US6582947B1 (en) 1998-12-11 1999-12-10 Medical use of gene and vector encoding a multisubstrate deoxyribonucleoside kinase
AT99963819T ATE290071T1 (de) 1998-12-11 1999-12-10 Medizinische verwendung eines gens und eines vektors, der eine multisubstrat- desoxyribonukleosidase kodiert
ES99963819T ES2239475T3 (es) 1998-12-11 1999-12-10 Nuevo uso medico del gen y el vector que codifican para una desoxirribonucleosidasa multisustrato.
EP99963819A EP1137764B1 (en) 1998-12-11 1999-12-10 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase
JP2000588348A JP2002532090A (ja) 1998-12-11 1999-12-10 多基質デオキシリボヌクレオシダーゼをコードする遺伝子及びベクターの新しい医学的使用
PCT/SE1999/002314 WO2000036099A1 (en) 1998-12-11 1999-12-10 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase
AU20185/00A AU778376B2 (en) 1998-12-11 1999-12-10 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase
DE69924003T DE69924003T2 (de) 1998-12-11 1999-12-10 Medizinische verwendung eines gens und eines vektors, der eine multisubstrat-desoxyribonukleosidase kodiert
DK99963819T DK1137764T3 (da) 1998-12-11 1999-12-10 Ny medicinsk anvendelse af gen og vektor, der koder for en multisubstrat deoxyribonucleosidase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9804298A SE9804298D0 (sv) 1998-12-11 1998-12-11 New medical use

Publications (1)

Publication Number Publication Date
SE9804298D0 true SE9804298D0 (sv) 1998-12-11

Family

ID=20413633

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9804298A SE9804298D0 (sv) 1998-12-11 1998-12-11 New medical use

Country Status (9)

Country Link
US (1) US6582947B1 (xx)
EP (1) EP1137764B1 (xx)
JP (1) JP2002532090A (xx)
AT (1) ATE290071T1 (xx)
AU (1) AU778376B2 (xx)
DE (1) DE69924003T2 (xx)
ES (1) ES2239475T3 (xx)
SE (1) SE9804298D0 (xx)
WO (1) WO2000036099A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003533225A (ja) * 2000-05-12 2003-11-11 クネヒト・ヴォルフガング 新規デオキシリボヌクレシドキナーゼ酵素の多基質変異体
WO2003100045A1 (en) 2002-05-23 2003-12-04 Wolfgang Knecht Plant thymidine kinases and their use
US20070202120A1 (en) * 2003-07-11 2007-08-30 Zgene A/S Yellow Fever Mosquito Deoxyribonucleoside Kinases And Its Use
JP5211303B2 (ja) * 2007-10-25 2013-06-12 独立行政法人産業技術総合研究所 蛋白質の製造方法
CN116479068B (zh) * 2023-05-08 2023-11-21 汇海(苏州)生物技术有限公司 一种利用生物酶制备n1-甲基-假尿苷单磷酸的方法

Also Published As

Publication number Publication date
AU778376B2 (en) 2004-12-02
DE69924003D1 (de) 2005-04-07
DE69924003T2 (de) 2006-04-13
ATE290071T1 (de) 2005-03-15
WO2000036099A1 (en) 2000-06-22
EP1137764A1 (en) 2001-10-04
US6582947B1 (en) 2003-06-24
EP1137764B1 (en) 2005-03-02
ES2239475T3 (es) 2005-09-16
JP2002532090A (ja) 2002-10-02
AU2018500A (en) 2000-07-03

Similar Documents

Publication Publication Date Title
KR950702626A (ko) 치료제로서 자체-안정화된 올리고누클레오티드(self-stabilized loigonucleotides as therapeutic agents)
DK0677056T3 (da) Oligonukleotid-alkylphosphonater og -alkylphosphonothioater
AU658634B2 (en) Synthetic catalytic oligonucleotide structures containing modified nucleotides
DK0702085T4 (da) Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
DE69403642D1 (de) 7-deazapurin modifizierte oligonukleotide
FI934937A (fi) Sekvenser av hcv-genom foer diagnostisk och terapi
CY1106041T1 (el) Καινοφανης συλλεκτινη
DK1175489T3 (da) Oligonukleotider indeholdende en antisense-sekvens stabiliseret af en sekundær struktur og farmaceutiske præparater indeholdende disse oligonukleotider
SE9804298D0 (sv) New medical use
EP1298208A3 (en) Ribozymes targeting a hiv tat sequence
KR930019822A (ko) 가광견병 바이러스 폴리뉴클레오티드 및 바이러스-내성 진핵세포의 제조를 위한 그의 용도
BR9815285A (pt) Vetores alfavìrus para vacina de paramixovìrus
WO1999028439A3 (fr) Erythrovirus et ses applications
PT722498E (pt) Celulas resistentes ou tolerantes a virus
PT1254663E (pt) Agente antiviral
Dukhan et al. 4′-Thio-RNA: Synthesis, Base Pairing Properties and Interaction with Dimerization Initiation Site of HIV-1
ATE449180T1 (de) Transglutaminase genprodukte
NO945020L (no) Selv-stabiliserende oligonukleotider som terapeutiske midler
Acosta Construction of mutated clones of the immunosuppressive strain of mice minute virus (MMvi)
TH23553EX (th) พาหะแสดงออกและการใช้พาหะเหล่านี้ในการเตรียมเซลของคนชนิดที่ต้านทาน hiv เพื่อใช้ในการบำบัดรักษา
TH23553A (th) พาหะแสดงออกและการใช้พาหะเหล่านี้ในการเตรียมเซลของคนชนิดที่ต้านทาน hiv เพื่อใช้ในการบำบัดรักษา